NR1H4 and metabolic dysfunction-associated steatotic liver disease: In NAFLD rats, the administration of probiotics is able to significantly increase the expression of FXR, FGF15 mRNA, and protein in the liver, upregulating the diversity of gut microbiota, downregulating the abundance of pathogenic bacteria and finally alleviating NAFLD [26].